The journey from discovery to market is challenging. Collaborative relationships among stakeholders such as drug developers, academic institutions, and industry partners offer an effective framework for addressing these challenges and successfully translating advanced therapy innovation.
In this webinar, we will explore the significance of these relationships and discuss the barriers, opportunities and responsibilities for emerging drug developers, tools providers, and early discovery teams. Panelists will share their experiences and describe specific examples of how being a member of an ecosystem afforded efficiencies and opportunities.
Key points addressed in this panel include: